These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 657587)

  • 1. The complement profile in relation to the "reactor" state: a study in the immediate post-partum period.
    Mak LW
    Clin Exp Immunol; 1978 Mar; 31(3):419-25. PubMed ID: 657587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement system in human colostrum: presence of nine complement components and factors of alternative pathway in human colostrum.
    Nakajima S; Baba AS; Tamura N
    Int Arch Allergy Appl Immunol; 1977; 54(5):428-33. PubMed ID: 885627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing of hemolytic complement components in domestic animals.
    Barta O; Hubbert NL
    Am J Vet Res; 1978 Aug; 39(8):1303-8. PubMed ID: 697137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypochlorite-induced alterations to canine serum complement.
    Boyer JT; Wyde P; Bier M
    Clin Exp Immunol; 1975 Aug; 21(2):345-50. PubMed ID: 1102168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activation of C5 in the fluid phase and in the absence of C3 through the classical pathway of the complement system.
    Kitamura H; Tsuboi M; Nagaki K
    Immunology; 1986 Jul; 58(3):459-65. PubMed ID: 3733147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The C5b-9 complex: subunit composition of the classical and alternative pathway-generated complex.
    Podack ER; Kolb WP; Muller-Eberhard HJ
    J Immunol; 1976 May; 116(5):1431-4. PubMed ID: 1270802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The properdin pathway: mechanisms of complement activation and analogies to the classical pathway.
    Fearon DT; Austen KF; Ruddy S
    Rheumatology; 1975; 6():2-16. PubMed ID: 1105744
    [No Abstract]   [Full Text] [Related]  

  • 8. C56 formation in the reaction mixture of isolated complement components through the classical complement pathway.
    Kitamura H; Tsuboi M; Nagaki K
    Int Arch Allergy Appl Immunol; 1985; 78(1):101-7. PubMed ID: 4030125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunoenzyme determination of the C5b-9 complex of the complement system].
    Rus H; Niculescu F; Cristea A; Vlaicu R
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1986; 31(1):35-40. PubMed ID: 3738363
    [No Abstract]   [Full Text] [Related]  

  • 10. C3-independent immune haemolysis: mechanism of membrane attack complex formation.
    Kitamura H; Tsuboi M; Nagaki K
    Immunology; 1986 Sep; 59(1):147-51. PubMed ID: 3759127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of immune haemolysis by a serum factor found in C3-deficient subjects.
    Kitamura H; Tsuboi M
    Immunology; 1989 Feb; 66(2):264-9. PubMed ID: 2925225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemolytic assays in agarose plates for components of the classical complement pathway: interference by the alternative pathway.
    Martin A; Lachmann PJ
    Clin Exp Immunol; 1977 Jan; 27(1):13-22. PubMed ID: 321155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inherited deficiency of the seventh component of complement associated with nephritis. Propensity to formation of C56 and related C7-consuming activity.
    Nemerow GR; Gewurz H; Osofsky SG; Lint TF
    J Clin Invest; 1978 Jun; 61(6):1602-10. PubMed ID: 350902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunological study in sickle cell disease patients: importance of the complement system].
    Sassi F; Bardi R; Neji T; Ayed K; Ben Dridi MF
    Tunis Med; 2003 Mar; 81(3):195-9. PubMed ID: 12793071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement-induced ultrastructural membrane lesions: requirement for terminal components.
    Packman CH; Rosenfeld SI; Weed RI; Leddy JP
    J Immunol; 1976 Nov; 117(5 Pt.2):1883-9. PubMed ID: 993584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terminal complement components play a role in the expression of C5a.
    Gresham HD; Renfer L; Hammer CH; Frank MM
    J Immunol; 1987 Feb; 138(3):838-41. PubMed ID: 3805718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyanate as an inactivator of complement proteins.
    Schultz DR; Arnold PI
    J Immunol; 1975 Dec; 115(6):1558-65. PubMed ID: 1184967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Complement system].
    Korol' SA
    Fiziol Zh; 1977; 23(3):408-16. PubMed ID: 326583
    [No Abstract]   [Full Text] [Related]  

  • 19. Hemolytic complement activity in normal human donor corneas.
    Mondino BJ; Hoffman DB
    Arch Ophthalmol; 1980 Nov; 98(11):2041-4. PubMed ID: 7002126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement levels in cigarette smokers: elevation of serum concentrations of C5, C9, and C1-inhibitor.
    Wyatt RJ; Bridges RB; Halatek DG
    J Clin Lab Immunol; 1981 Sep; 6(2):131-5. PubMed ID: 7288869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.